Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PYRIMETHAMINE USP, with a corresponding US DMF Number 36098.
Remarkably, this DMF maintains an Active status since its submission on July 09, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 30, 2021, and payment made on July 08, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II